Ehlanganiswe nezinye izici eziningana, i-Victoza ingasiza labo abane-PCOS
I-Polycystic i-ovary syndrome (i-PCOS) yisimo esivamile kubantu besifazane abaneminyaka yobudala yokuzala futhi kungabangela ukungabi nabantwana kanye nezinkinga zemithi. Amaphesenti angaba ngu-50 kuya kwangu-70 kwabesifazane abane-PCOS futhi abhekene nokuphikiswa kwe-insulin, okukholelwa ukuthi iyimbangela eyinhloko yesimo. Okungenani isigamu sabesifazane abane-PCOS singaphezu komzimba ngokweqile noma kukhuluphele. Nakuba i-PCOS ingenza kube nzima ukunciphisa isisindo, izifundo zibonise ukuthi ukulahlekelwa kwesisindo samaphesenti angu-5 kuya ku-10 wesisindo somzimba kungathuthukisa izici ezimbili ze-PCOS.
Uma une-PCOS futhi uthola kunzima ukulahlekelwa isisindo, imithi ingasiza.
I-Metformin , imithi yesifo sikashukela, imithi ethandwayo esetshenziselwa odokotela ukuphatha ukwelashwa kwe-insulin ku-PCOS, kodwa ayikho ekulahlekeni kwesisindo esikhulu. Ucwaningo lubonisa ukuthi omunye umuthi wesifo sikashukela, uVictoza, ungasiza labo abane-PCOS ukuthi balahlekelwe isisindo futhi bathuthukise izimpawu zokumaketha. I-Victoza, kanye ne-metformin nezindlela zokuphila, kungase kube indlela ephumelelayo yokulahlekelwa isisindo uma unayo i-PCOS futhi uhluleka ukulahlekelwa isisindo naphezu kwezinguquko zokudla, i-insulin-ukunciphisa izithako, ukuvivinya umzimba kanye ne-metformin.
Kuyini i-Victoza?
I-Victoza (i-Liraglutide) imithi ejojowe ene-structure efana ne-glucagon-like peptide-1 (GLP-1). I-GLP-1 iyi-hormone yamathumbu eyenza i-glucose-eyashukumisa ukuvimba ukuvikela i-glucagon, ivimba ukubambezeleka kwe-gastric, nokunciphisa ukudla nokudla. U-Victoza wamukelwa ngo-2010, kulabo abane- type 2 yesifo sikashukela , kodwa kungasiza labo abane-PCOS.
I-Victoza iboniswe ukuthi ihle kakhulu HbA1c nesisindo somzimba. I-Victoza nayo inomthelela omkhulu ekulahlekelweni kwesisindo kanye nencishwana encishisiwe yokulashwa kwesifo sikashukela kubantu abangaboni kakhulu isifo sikashukela, kangangokuthi i-Advisory Committee ye-Endocrinologic ne-Metabolic Drugs Committee ivotelwe ukuba iViczaza ivunyelwe ukuphathwa kwesisindo esingapheli.
Imiphumela emihle ekucindezelweni kwegazi kanye namazinga e-cholesterol aboniswe kubantu abathatha i-Victoza.
I-Victoza isebenza ngokunciphisa ukukhululwa kokudla okuvela esiswini sakho. Ukuba ne-PCOS kungalimaza amazinga akho e-hormone elawula ukudla. Ukuthatha i-Victoza kungakusiza uzizwe ugcwele masinyane, futhi ujabulele kancane kokudla. Ngenxa yalokho, ngenkathi uthatha i-Victoza, uzodla ukudla okuncane futhi ngaleyo ndlela ulahlekelwe isisindo.
Okushiwo yi-Research
Esikhathini sokutadisha, abesifazane abane-PCOS abathatha i-Victoza ne-Metformin izinyanga ezingu-7 babonisa ukulahlekelwa kwesisindo samapounds angu-20. Amaphesenti angamashumi ayisishiyagalolunye nambili kwabesifazane alahlekelwe amaphesenti angaphezu kwangu-5 kanti amaphesenti angu-33 alahlekelwa amaphesenti angaphezu kwezingu-10 esisindo sabo sokuqala. Ngaphandle kokuthatha i-Victoza, abesifazane besifundo babedla ukudla okungezansi kwe-glycemic ngaphandle komkhawulo we-caloric, bathola isiqondiso ngumuntu wokudla , futhi bahlanganyela emaminithini angu-45 okuvivinya umzimba okungenani kathathu ngesonto ngalinye.
Ucwaningo oluncane luphenye umphumela we-Victoza ne-Metformin kuziguli ze-PCOS. Kubonisa ukulahleka okukhulu kwesisindo ngemithi ehlanganisiwe kune-metformin yedwa.
Okufanele Ukwazi Ngokuthatha Victoza
Uma unayo i-PCOS futhi ungeke ulahlekelwe isisindo naphezu kokudla okunempilo nokuphila , ukwengeza u-Victoza ku-regimen yakho kungase kusize.
Uma unesithakazelo sokuzama u-Victoza, khuluma nodokotela wakho. I-Victoza ingabangela imiphumela emibi yokwelapha ekutholeni imithi, kuhlanganise nokucwenga, ukuhlanza, isifo sohudo, ukuqothulwa, nokuhlukunyezwa kwesisu. Lezi zimpawu ngokuvamile zihamba ngemva kokuthatha lesi sidakamizwa isikhathi eside. Ezifundweni zezilwane, uVictoza wayehlotshaniswa nezicubu ze-thyroid. Akukwazi ukuthi i-Victoza ibangela izicubu ze-thyroid noma umdlavuza kubantu. Yize kuyindlela yokwelapha ethembisayo, kuzodingeka izifundo eziningi ukuhlola ukusetshenziswa kwe-Victoza isikhathi eside.
> Imithombo:
> Bode B. Uhlolojikelele lwe-Pharmacokinetics, Efficacy, kanye nokuphepha kweLiraglutide. Isifo sikashukela se-Clinic (2012) 97: 27-4210.1016.
> Rasmussen CB, Lindenberg S. Imiphumela yeLiraglutide ekulahlekeni kwesisindo kwabesifazane abane-Polycystic Ovary Syndrome: Isifundo Sokuhlola. I-Front Endocrinol (iLausanne). 2014 Aug 27; 5: 140.
> Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A. Ukwelashwa Okubambisene Nesikhathi Esifushane Ne-Liraglutide ne-Metformin Kuholela Ekulahlekelweni Kwesisindo Esiqakathekile Kwabesifazane Abakhulu Abaphethe I-Polycystic Ovary Syndrome kanye Nezimpendulo Ezimbi Zangaphambili KwaMetformin. I-Eur J Endocrinol. 2014 Mar; 170 (3): 451-9.
> Moran LJ, Noakes M, Clifton PM, et al. I-Postprandial Ghrelin, i-Cholecystokinin, i-Peptide YY, ne-Appetite Ngaphambi Kamuva nangemva kokuncipha kwesisindo ku-Overweight Women With Without Polycystic Ovary Syndrome. I-Am J Clin Nutr . 2007; 86 (6): 1603-1610.
> Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL. Imiphumela ye-Glucagon-Njenga-Peptide-1 I-Agonists Yokulonda Isisindo: Ukubuyekezwa Kwesistimu kanye Nokuhlaziywa Kwezinguquko Ezilawulwa Ngaloluhlelo. I-BMJ (2012): 344.